Retiro De Equipo (Recall) de ExacTrac Patient Positioning System with software versions 6.0, 6.1, 6.2, 6.5

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Brainlab Australia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    When using exactrac on a varian clinac or varian truebeam system equipped with the adi, beam requests of the treatment application have to be authorized by exactrac to enable treatment. as per the ifu, if no patient data is loaded in exactrac, exactrac always authorizes every beam request from the varian side. this is required and intended for clinical treatments where exactrac is not used for patient positioning. brainlab is clarifiying that the beam authorization by exactrac via adi is not a safety feature to ensure correct patient positioning before treatment.For any treatments performed with exactrac always verify that exactrac confirms the target position by displaying the ok icon. if a deviation of the patient position from the planned treatment position remains undetected by the user and the actual treatment beam that has been previously authorized by exactrac via adi is initialized, underdose of the planned target and/or overdose of healthy tissue could occur.
  • Acción
    Brainlab is advising users to always follow the IFU during use and to verify that ExacTrac confirms the target position by displaying the OK icon. Brainlab is providing updated Instructions for use. For treatments that have already been performed, the actual patient position during treatment can be reviewed in the treatment report of ExacTrac, and by using the Review function in the ExacTrac software.


  • Modelo / Serial
    ExacTrac Patient Positioning System with software versions 6.0, 6.1, 6.2, 6.5ARTG Number: 121226 (Brainlab Australia Pty Ltd - ExacTrac / Novalis Body - Patient positioning device, diagnostic imaging/radiotherapy, whole body)
  • Manufacturer